Can VIP Nasal Spray Help Joint Inflammation and Fatigue?

No study in people has tested vasoactive intestinal peptide (VIP) nasal spray for joint inflammation or tired, achy joints. The joint results come from mice with lab-induced arthritis. The human nasal-spray results come from a small study, with no placebo group, of people with a mold-related inflammatory illness called CIRS. VIP nasal spray is a compounded medicine, not an FDA-approved one, and online clinics with final prices list it at $189 to $219 a month.

Is there any proof VIP helps joint inflammation in people?

Not yet. The joint evidence comes from animals, not women. In a 2001 mouse study in Nature Medicine, mice with collagen-induced arthritis (arthritis triggered in the lab) developed arthritis less often and less severely when treated with VIP. Joint swelling stopped completely, and so did the breakdown of cartilage and bone. VIP did this by calming both inflammation and the immune system's attack on the joints.

In a 2019 review, the same research group says two decades of lab and animal work show VIP helps at every stage of rheumatoid arthritis development in experimental models. The authors still call it a potential treatment, not an established one.

The review also explains why VIP hasn't made the jump to treating joints in people. Enzymes in the body break it down fast. It also binds several different receptors all over the body, so giving it body-wide could cause effects nobody wants. That's why researchers are still working on more stable versions.

The mouse study didn't test a nasal spray, and none of this research measured fatigue or joint tiredness. For now, the joint story is an early, promising lab idea.

Where has VIP nasal spray been tested in humans?

In people with chronic inflammatory response syndrome (CIRS). CIRS is an inflammatory illness some people develop after living or working in water-damaged, moldy buildings. In an open-label study of 20 people with CIRS who were still sick after standard treatment, VIP improved their symptoms and their immune lab markers. Their symptoms dropped to the level of healthy controls, and markers including C4a, TGF-beta1, MMP-9 and VEGF returned to normal in most of them.

Open-label means everyone knew they were getting VIP and no one got a placebo. That makes it hard to tell how much of the improvement came from the spray itself.

A 2024 review of CIRS treatment evidence lists the VIP papers. These include a 2017 paper reporting that intranasal VIP restored volume to grey matter areas of the brain in people with CIRS. Most of the VIP work in CIRS comes from one research group, led by Dr. Ritchie Shoemaker.

VIP has also been used in hospital medicine under the drug name aviptadil, for pulmonary hypertension (high blood pressure in the lungs) and sarcoidosis, according to the 2019 VIP review. Neither use is about joints or energy.

Who is VIP nasal spray prescribed for right now?

People with mold-related illness, plus people buying it for general wellness. MoldCo, whose founding physician is Dr. Ritchie Shoemaker, is the clinic tied most closely to the human research. MoldCo's care page says: "VIP is not FDA approved but is prescribed for mold-related illnesses based on published clinical experience." VIP nasal spray is phase 3 of its treatment, after a binder and an EDTA nasal spray.

General wellness telehealth sites sell the same spray for broader goals, with no promise about joints. HydraMed describes its VIP nasal spray program as designed to support "broader longevity and wellness goals." It says the spray is made by licensed U.S. 503A compounding pharmacies, and that "Compounded medications are not FDA-approved."

A compounded medicine is made to order by a pharmacy for one patient. It hasn't been through FDA review for safety or effectiveness, and a provider still has to approve it. Apex Rx states: "The FDA does not review or approve any compounded medications for safety or effectiveness. Availability varies by state." It dispenses VIP only where a licensed physician decides it is clinically appropriate.

If your aches and fatigue started after time in a damp or moldy home or office, tell your clinical team. CIRS is the one setting where VIP nasal spray has human data.

How much does VIP nasal spray cost?

Clinics with final prices charge $189 to $219 a month for VIP nasal spray, before any membership or visit fees.

Over a year, HydraMed's monthly plan comes to $2,268. MoldCo's spray alone comes to $2,628, or $3,576 with the membership, plus $129 for a virtual provider visit. That is what you would pay for a spray with no human joint data.

What side effects can VIP nasal spray cause?

Light-headedness is the side effect listed in the human research, and nose irritation showed up in rats. The 2024 CIRS treatment review lists light-headedness among the side effects reported with VIP.

In a rat safety study, VIP nasal spray caused minor irritation inside the nose. It cleared on its own within a week after treatment stopped.

Experiments in mice and rats in the same study found the nasal route carried VIP into the brain. That's part of why researchers study it for brain symptoms, and it's a good reason to ask your clinical team what to watch for.

Joints that stay swollen, stiff or hot need a proper workup before any peptide. Rheumatoid arthritis is a chronic autoimmune disease that inflames the joints and goes on to destroy cartilage and bone. A wellness spray can't tell you what's going on in your joints.

Hot or Nothing doesn't sell VIP. If you want more energy and a body that recovers better, take the quiz and tell our clinical team about your aches, your fatigue and what you've already tried. Our energy and recovery plans include treatments such as NAD+, sermorelin and BPC-157, and your clinical team decides which one fits your goal.